The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
An early stage clinical trial of an mRNA-based HIV vaccine could begin this month, according to the U.S. National Library of Medicine clinical trial registry.
The medication known as PrEP can prevent HIV. Insurers are supposed to cover it at no cost to patients. Some aren't doing that.
Tweets by @HIV+Hep
31 minutes ago
Make a difference after #WorldHepatitisDay by calling for U.S. leadership to commit the resources + action to end #hepatitisC. #hepcantwait, esp. when we have the tools to make much needed progress now. Read more from @HIVHep’s Carl Schmid on how: https://t.co/owVSnEr9eB https://t.co/AgcXy7Tj7A
Make a difference after #WorldHepatitisDay by calling for U.S. leadership to commit the resources + action to end #hepatitisC. #hepcantwait, esp. when we have the tools to make much needed progress now. Read more from @HIVHep’s Carl Schmid on how: https://t.co/owVSnEr9eB https://t.co/AgcXy7Tj7A
6 hours ago
Join @HIVHep’s Carl Schmid on 9/21, 5:30pm ET, @ the virtual @2021SYNC, where he will address the #ACA requirement for insurers to offer #PrEP w/o patient cost-sharing & ways to increase #PrEP uptake. To register & see the conference agenda, please visit https://t.co/x9p29DJ27F. https://t.co/3SvOLB1iV4
Join @HIVHep’s Carl Schmid on 9/21, 5:30pm ET, @ the virtual @2021SYNC, where he will address the #ACA requirement for insurers to offer #PrEP w/o patient cost-sharing & ways to increase #PrEP uptake. To register & see the conference agenda, please visit https://t.co/x9p29DJ27F. https://t.co/3SvOLB1iV4
7 hours ago
Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance https://t.co/5ccg86Jw9c
Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance https://t.co/5ccg86Jw9c